Bortezomib, Thalidomide, and Dexamethasone (VTD) Induction Results in Better Overall Survival than Adriamycin, Thalidomide, and Dexamethasone (ATD) Induction in Previously Untreated Myeloma Patients Eligible for Transplants. - Chen JF; Xiao LF; Zhang R; Zeng ZH; Li YX; Meng XY (Acta haematologica, 2017)